Pain catastrophizing decreases over time in patients with RA who respond to DMARD treatment.
Preliminary evidence has found an association between the cannabinoid system and other rheumatic conditions, but the studies have not provided conclusive results that could drive recommendations.
The assessment of patient-reported components of the DAS28 can be a useful way to identify patients with fibromyalgic RA.
Widespread nonarthritic pain is linked to worse patient-reported and composite psoriatic arthritis activity measures.
Factors to be considered when choosing the correct nonsteroidal anti-inflammatory drug (NSAID) for arthritis include effectiveness, concurrent health conditions, and frequency of use.
The percentage of patients with septic arthritis related to opioid or injection drug use was found to have increased from 2000 to 2013.
Investigators sought to evaluate intra-articular onabotulinumtoxinA 400 U and 200 U in reducing symptoms of knee OA in patients with nociceptive pain.
Consensi combines amlodipine besylate, a calcium-channel blocker (CCB), and celecoxib, a nonsteroidal anti-inflammatory drug (NSAID).
The relationship between pain and cognitive dysfunction was explained by sleep disturbance and depressive symptoms.
Illness perceptions are important in the relationship between back pain and health-related quality of life in patients suspected of axial spondyloarthritis.
Baseline depressive symptoms were associated with pain and disability in adolescents with juvenile idiopathic arthritis.
In patients with rheumatoid arthritis or osteoarthritis who are at higher risk for cardiovascular events, celecoxib may be safer compared with naproxen or ibuprofen when these drugs are taken alone or in combination with aspirin.
A set of psychosocial and sociodemographic factors may be associated with pain levels in patients with knee osteoarthritis.
Patients who received a repeat Zilretta injection experienced a 64% improvement in Western Ontario and McMaster Universities Arthritis Index (WOMAC)-A (pain), a 66% improvement in WOMAC-B (stiffness), a 64% improvement on WOMAC-C (function), and improvement represented by a doubling of the KOOS Quality of Life subscale score by Week 4.
Consensus recommendations on the use of biosimilars for the treatment of patients with rheumatologic diseases were recently published in Annals of the Rheumatic Diseases.
Ketoprofen was found to be effective in relieving moderate to severe pain in patients with rheumatoid arthritis.
No association was found between current statin use and the risk of developing systemic lupus erythematosus.
Diffuse alveolar hemorrhage in childhood-onset SLE is associated with serious disease flares, and is complicated by sepsis and high mortality rate.
Researchers have created a set of 21 candidate criteria for systemic lupus erythematosus as apart of a multiphase development of a set of criteria for the disease.
The FDA approved Duzallo, a fixed-dose tablet combining lesinurad and allopurinol, for the treatment of uncontrolled gout.
Fractional exhaled nitric oxide monitoring may provide a potential biomarker of disease activity and signify the emergency of pulmonary involvement in children with SLE.
Clinicians who treat osteoporotic fractures should prescribe anti-osteoporotic drugs to prevent secondary vertebral and non-vertebral fractures.
Underlying synovitis and enthesitis may go undetected in clinical findings, but can be detected by power Doppler ultrasounds.
Researchers from the Feinstein Institute for Medical Research may have identified a potential cause for lupus, which may lead to new treatment options.
The risk for death associated with SLE remains high for patients with SLE-associated PAH and researchers have identified the biomarkers that may lead to early detection.
Patients with RA have a significantly higher risk of cardiovascular disease, and cardiac magnetic resonance can help with early diagnosis.
A sizeable percentage of patients with rheumatoid arthritis who are in clinical remission have evidence of disease activity on magnetic resonance imaging of the foot that is mostly affected.
Eating fish at least twice a week may significantly reduce the pain and swelling associated with rheumatoid arthritis.
In patients with tophaceous gout, combination therapy of lesinurad plus febuxostat is more effective at reducing serum urate levels than febuxostat monotherapy.
Cumulative steroid dosage is a risk factor for the development of osteonecrosis, which is the most frequent type of damage in lupus patients.
Clinical Pain Advisor Articles
- Opioid Use Disorders: Advances in Pharmacotherapy Provide Long-term Results
- Abuse-Deterrent Opioid Formulations: Barriers to Broader Use
- Women Frequently Prescribed High Doses of Opioids After Vaginal Delivery
- Notifications by PDMPs May Not Effectively Reduce Opioid Misuse
- Medical Cannabis Legalization Associated With Reduced Schedule III Opioid Prescriptions
- Neuropathic Pain Medications
- Higher Buprenorphine Dose May Not Increase Severity of Neonatal Abstinence Syndrome
- Terms Used for Addiction May Be Associated With Explicit, Implicit Bias
- Ketamine Infusions May Be Effective for Refractory Headache
- Physical, Psychosocial Activity May Be Protective Against Development of Chronic Pain in Older Adults
- Prioritizing Rest in Hospital Settings: Poor Sleep Increases Costs, Complications, and Mortality
- Pain Catastrophizing Decreases in Rheumatoid Arthritis After DMARD Initiation
- Addressing Commercial Incentives in the Medical Device Industry
- Cancer Patients Treated With Step III Opioids Often Have Sleep Disturbances
- Individual, Group Low Literacy Self-Management Program for Chronic Pain May Be Effective